Financial Perspectives’s Gilead Sciences GILD Stock Holding History

Financial Perspectives’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Hold	8,055	–	–	0.25%	62
2026 Q1	$1.12M	Hold	8,055	–	–	0.31%	52
2025 Q4	$989K	Hold	8,055	–	–	0.27%	57
2025 Q3	$894K	Buy	8,055 +1	+0%	+$114	0.25%	58
2025 Q2	$893K	Hold	8,054	–	–	0.27%	56
2025 Q1	$902K	Hold	8,054	–	–	0.31%	50
2024 Q4	$744K	Hold	8,054	–	–	0.25%	59
2024 Q3	$675K	Hold	8,054	–	–	0.23%	59
2024 Q2	$553K	Buy	8,054 +1	+0%	+$67	0.2%	66
2024 Q1	$590K	Buy	8,053 +644	+9%	+$49.5K	0.22%	65
2023 Q4	$600K	Buy	7,409 +41	+0.6%	+$3.19K	0.24%	58
2023 Q3	$552K	Buy	7,368 +326	+5%	+$25.1K	0.25%	60
2023 Q2	$543K	Hold	7,042	–	–	0.24%	62
2023 Q1	$584K	Buy	7,042 +1	+0%	+$83	0.28%	56
2022 Q4	$605K	Hold	7,041	–	–	0.31%	54
2022 Q3	$434K	Buy	7,041 +6,345	+912%	+$400K	0.24%	62
2022 Q2	$43K	Hold	696	–	–	0.02%	251
2022 Q1	$41.4K	Buy	696 +1	+0.1%	+$64	0.02%	271
2021 Q4	$50.5K	Hold	695	–	–	0.02%	242
2021 Q3	$48.6K	Hold	695	–	–	0.02%	239
2021 Q2	$47.9K	Sell	695 -44,212	-98%	-$2.95M	0.02%	260
2021 Q1	$695K	Buy	44,907 +44,212	+6,361%	+$2.85M	0.03%	249
2020 Q4	$40.5K	Buy	695 +1	+0.1%	+$60	0.02%	248
2020 Q3	$43.9K	Hold	694	–	–	0.03%	212
2020 Q2	$53.4K	Sell	694 -566	-45%	-$43.4K	0.04%	183
2020 Q1	$94.2K	Hold	1,260	–	–	0.08%	117
2019 Q4	$81.9K	Buy	+1,260	New	+$82.1K	0.06%	140

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Financial Perspectives's GILD Position: Q2 2026 in Review

Financial Perspectives held its Gilead Sciences (GILD) position steady in Q2 2026 at 8,055 shares worth $1.02M. The position accounts for 0.25% of the portfolio, ranked #62.

Financial Perspectives first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.12M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Financial Perspectives held 8,055 shares of Gilead Sciences worth $1.02M as of Q2 2026.
Financial Perspectives left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.25% of Financial Perspectives's portfolio in Q2 2026, its #62 holding.
Financial Perspectives first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
Financial Perspectives's Gilead Sciences position peaked at $1.12M in Q1 2026.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financial Perspectives's 13F filing for Q2 2026, filed 24 Jul 2026.